|
Q4 FY2026
As of Dec 31, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current Assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net of credit losses of $19,019 and $7,326 as of June 30, 2026 and December 31, 2025, respectively | |||||||||||||
| Inventories, net of reserves of $10,926 and $34,524 as of June 30, 2026 and December 31, 2025, respectively | |||||||||||||
| Prepaids and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property and Equipment, at Cost: | |||||||||||||
| Less - accumulated depreciation | |||||||||||||
| Property and equipment, net | |||||||||||||
| Other Assets: | |||||||||||||
| Operating lease right of use asset, net | |||||||||||||
| Intangible assets, net | |||||||||||||
| Security deposit | |||||||||||||
| Other non-current assets | |||||||||||||
| Total Assets | |||||||||||||
| Liabilities | |||||||||||||
| Current Liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses | |||||||||||||
| Current portion of operating lease payable | |||||||||||||
| Notes payable - convertible notes, net of unamortized debt discount of $206,464 and $0 as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||
| Notes payable | |||||||||||||
| Total notes payable | |||||||||||||
| Customer deposits | |||||||||||||
| Share liability | |||||||||||||
| Warrant liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Non-Current Liabilities: | |||||||||||||
| Operating lease payable, net of current portion | |||||||||||||
| Other non-current liabilities | |||||||||||||
| Total non-current liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders’ Equity | |||||||||||||
| Convertible Series B Preferred stock, $0.001 par value; 5,000,000 shares authorized, 3,796,907 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |||||||||||||
| Convertible Series B Preferred Stock | |||||||||||||
| Total convertible Series B Preferred stock, $0.001 par value; 5,000,000 shares authorized, 3,796,907 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |||||||||||||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 12,468,059 and 10,652,812 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||||||
| Additional paid in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total Liabilities and Stockholders’ Equity | |||||||||||||
Loading...
